glp 1 drugs and alzheimer's Older GLP-1 drug may help protect brains of patients GLP-1 Microdosing, Brain Health &

Rybelsus (semaglutide tablets), the first GLP-1 in a tablet approved in the US [press release]

B., Rosenblat, J

The warning is based on animal studies that showed thyroid C-cell tumors in rodents

More encouragingly, a phase II randomized controlled trial (RCT) of lixisenatide ( n = 156) reported slower motor decline over 12 months (159), while liraglutide improved nonmotor symptoms but not motor endpoints (160)

The investigation specifically showed that these drugs did not increase the risk of any fractures, confirming their safety profile in clinical practice ( 4.6 Ophthalmological effects 4.6.1 Glaucoma GLP-1R agonists exhibit anti-inflammatory and neuroprotective properties, suggesting they could also be beneficial in neurodegenerative diseases ( A recent registry-based case-control study, summarized in Table 2 , involving 1,961 patients found that the use of GLP-1R agonists is linked to a lower risk of glaucoma (Sterling et al., 2021 (79)

These steps can help you not only lose weightbut feel stronger, healthier, and more in control of your well-being for years to come